Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Peter Grant Miller, M.D.

Title
Institution
Department
Address
Phone
Fax

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. K08CA263183 (MILLER, PETER GRANT) Aug 20, 2021 - Jul 31, 2026
    NIH
    Role of PPM1D and PPM1D mutations in hematopoiesis and response to stress
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Sella T, Fell GG, Miller PG, Gibson CJ, Rosenberg SM, Snow C, Stover DG, Ruddy KJ, Peppercorn JM, Schapira L, Borges VF, Come SE, Warner E, Frank E, Neuberg DS, Ebert BL, Partridge AH. Patient perspectives on testing for clonal hematopoiesis of indeterminate potential. Blood Adv. 2022 12 27; 6(24):6151-6161. PMID: 36129839; PMCID: PMC9791300.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  2. Miller PG, Fell GG, Foy BH, Scherer AK, Gibson CJ, Sperling AS, Burugula BB, Nakao T, Uddin MM, Warren H, Bry L, Pozdnyakova O, Frigault MJ, Bick AG, Neuberg D, Higgins JM, Mansour MK, Natarajan P, Kim AS, Kitzman JO, Ebert BL. Clonal hematopoiesis of indeterminate potential and risk of death from COVID-19. Blood. 2022 11 03; 140(18):1993-1997. PMID: 36096050; PMCID: PMC9474399.
    Citations:    Fields:    Translation:Humans
  3. Sperling AS, Guerra VA, Kennedy JA, Yan Y, Hsu JI, Wang F, Nguyen AT, Miller PG, McConkey ME, Quevedo Barrios VA, Furudate K, Zhang L, Kanagal-Shamanna R, Zhang J, Little L, Gumbs C, Daver N, DiNardo CD, Kadia T, Ravandi F, Kantarjian H, Garcia-Manero G, Futreal PA, Ebert BL, Takahashi K. Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms. Blood. 2022 10 20; 140(16):1753-1763. PMID: 35512188; PMCID: PMC9837415.
    Citations:    Fields:    
  4. Freedman RA, Li T, Sedrak MS, Hopkins JO, Tayob N, Faggen MG, Sinclair NF, Chen WY, Parsons HA, Mayer EL, Lange PB, Basta AS, Perilla-Glen A, Lederman RI, Wong A, Tiwari A, McAllister SS, Mittendorf EA, Miller PG, Gibson CJ, Burstein HJ. 'ADVANCE' (a pilot trial) ADjuVANt chemotherapy in the elderly: Developing and evaluating lower-toxicity chemotherapy options for older patients with breast cancer. J Geriatr Oncol. 2023 Jan; 14(1):101377. PMID: 36163163.
    Citations:    Fields:    
  5. Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, Wong WJ, Weeks LD, Lin AE, Miller PG, Gibson CJ, Sekar A, Schaefer IM, Neuberg D, Stone RM, Bick AG, Uddin MM, Griffin GK, Jaiswal S, Natarajan P, Nigrovic PA, Rao DA, Ebert BL. TET2-mutant clonal hematopoiesis and risk of gout. Blood. 2022 09 08; 140(10):1094-1103. PMID: 35714308; PMCID: PMC9461470.
    Citations:    Fields:    
  6. Sellar RS, Sperling AS, Slabicki M, Gasser JA, McConkey ME, Donovan KA, Mageed N, Adams DN, Zou C, Miller PG, Dutta RK, Boettcher S, Lin AE, Sandoval B, Quevedo Barrios VA, Kovalcik V, Koeppel J, Henderson EK, Fink EC, Yang L, Chan A, Pokharel SP, Bergstrom EJ, Burt R, Udeshi ND, Carr SA, Fischer ES, Chen CW, Ebert BL. Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells. J Clin Invest. 2022 08 15; 132(16). PMID: 35763353; PMCID: PMC9374383.
    Citations:    Fields:    
  7. Miller PG, Sathappa M, Moroco JA, Jiang W, Qian Y, Iqbal S, Guo Q, Giacomelli AO, Shaw S, Vernier C, Bajrami B, Yang X, Raffier C, Sperling AS, Gibson CJ, Kahn J, Jin C, Ranaghan M, Caliman A, Brousseau M, Fischer ES, Lintner R, Piccioni F, Campbell AJ, Root DE, Garvie CW, Ebert BL. Allosteric inhibition of PPM1D serine/threonine phosphatase via an altered conformational state. Nat Commun. 2022 06 30; 13(1):3778. PMID: 35773251; PMCID: PMC9246869.
    Citations:    Fields:    Translation:HumansCells
  8. Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer S, Alotaibi AS, Mohamed SF, Miller PG, Guber E, Weinstein S, Yacobovich J, Nikiforow S, Ebert BL, Lane A, Pasvolsky O, Raanani P, Nagler A, Berliner N, Daver N, Ellis M, Jordan MB. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis. Blood. 2022 02 17; 139(7):1098-1110. PMID: 34780598; PMCID: PMC8854682.
    Citations: 3     Fields:    Translation:Humans
  9. Khadka P, Reitman ZJ, Lu S, Buchan G, Gionet G, Dubois F, Carvalho DM, Shih J, Zhang S, Greenwald NF, Zack T, Shapira O, Pelton K, Hartley R, Bear H, Georgis Y, Jarmale S, Melanson R, Bonanno K, Schoolcraft K, Miller PG, Condurat AL, Gonzalez EM, Qian K, Morin E, Langhnoja J, Lupien LE, Rendo V, Digiacomo J, Wang D, Zhou K, Kumbhani R, Guerra Garcia ME, Sinai CE, Becker S, Schneider R, Vogelzang J, Krug K, Goodale A, Abid T, Kalani Z, Piccioni F, Beroukhim R, Persky NS, Root DE, Carcaboso AM, Ebert BL, Fuller C, Babur O, Kieran MW, Jones C, Keshishian H, Ligon KL, Carr SA, Phoenix TN, Bandopadhayay P. PPM1D mutations are oncogenic drivers of de novo diffuse midline glioma formation. Nat Commun. 2022 02 01; 13(1):604. PMID: 35105861; PMCID: PMC8807747.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  10. Miller PG, Qiao D, Rojas-Quintero J, Honigberg MC, Sperling AS, Gibson CJ, Bick AG, Niroula A, McConkey ME, Sandoval B, Miller BC, Shi W, Viswanathan K, Leventhal M, Werner L, Moll M, Cade BE, Barr RG, Correa A, Cupples LA, Gharib SA, Jain D, Gogarten SM, Lange LA, London SJ, Manichaikul A, O'Connor GT, Oelsner EC, Redline S, Rich SS, Rotter JI, Ramachandran V, Yu B, Sholl L, Neuberg D, Jaiswal S, Levy BD, Owen CA, Natarajan P, Silverman EK, van Galen P, Tesfaigzi Y, Cho MH, Ebert BL. Association of clonal hematopoiesis with chronic obstructive pulmonary disease. Blood. 2022 01 20; 139(3):357-368. PMID: 34855941; PMCID: PMC8777202.
    Citations: 5     Fields:    Translation:HumansAnimals
  11. Miller PG, Sperling AS, Brea EJ, Leick MB, Fell GG, Jan M, Gohil SH, Tai YT, Munshi NC, Wu CJ, Neuberg DS, Maus MV, Jacobson C, Gibson CJ, Ebert BL. Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy. Blood Adv. 2021 08 10; 5(15):2982-2986. PMID: 34342642; PMCID: PMC8361461.
    Citations: 4     Fields:    Translation:Humans
  12. Miller PG, Sperling AS, Gibson CJ, Pozdnyakova O, Wong WJ, Manos MP, Buchbinder EI, Hodi FS, Ebert BL, Davids MS. A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade. Haematologica. 2021 02 01; 106(2):651-654. PMID: 33054119.
    Citations: 2     Fields:    Translation:Humans
  13. Miller PG, Sperling AS, Gibson CJ, Viswanathan K, Castellano C, McConkey M, Ceremsak J, Taylor MS, Birndt S, Perner F, Arnason J, Agrawal M, Schram AM, Nikiforow S, Pihan G, Hasserjian RP, Aster JC, La Rosée P, Morgan EA, Berliner N, Ebert BL. Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis. Blood. 2020 12 24; 136(26):3051-3055. PMID: 32961550; PMCID: PMC7770567.
    Citations: 6     Fields:    Translation:HumansAnimals
  14. Slabicki M, Yoon H, Koeppel J, Nitsch L, Roy Burman SS, Di Genua C, Donovan KA, Sperling AS, Hunkeler M, Tsai JM, Sharma R, Guirguis A, Zou C, Chudasama P, Gasser JA, Miller PG, Scholl C, Fröhling S, Nowak RP, Fischer ES, Ebert BL. Small-molecule-induced polymerization triggers degradation of BCL6. Nature. 2020 12; 588(7836):164-168. PMID: 33208943.
    Citations: 24     Fields:    Translation:HumansCells
  15. Miller PG, Steensma DP. Implications of Clonal Hematopoiesis for Precision Oncology. JCO Precis Oncol. 2020 Nov; 4:639-646. PMID: 35050749.
    Citations: 2     Fields:    
  16. Miller PG, Gibson CJ, Mehta A, Sperling AS, Frederick DT, Manos MP, Miao B, Hacohen N, Hodi FS, Boland GM, Ebert BL. Fitness Landscape of Clonal Hematopoiesis Under Selective Pressure of Immune Checkpoint Blockade. JCO Precis Oncol. 2020; 4. PMID: 33015529; PMCID: PMC7529531.
    Citations: 4     Fields:    
  17. Miller PG, Niroula A, Ceremsak JJ, Gibson CJ, Taylor MS, Birndt S, Perner F, Arnason J, Sperling AS, Agrawal M, Schram AM, Nikiforow S, Pihan G, Hasserjian RP, Aster JC, La Rosée P, Morgan EA, Berliner N, Ebert BL. Identification of germline variants in adults with hemophagocytic lymphohistiocytosis. Blood Adv. 2020 03 10; 4(5):925-929. PMID: 32150605.
    Citations: 3     Fields:    Translation:HumansCells
  18. Miller PG, Li G, Singal G. PD-L1 Status and Survival in Patients With Lung Cancer-Reply. JAMA. 2019 08 27; 322(8):783-784. PMID: 31454037.
    Citations: 1     Fields:    Translation:Humans
  19. Boettcher S, Miller PG, Sharma R, McConkey M, Leventhal M, Krivtsov AV, Giacomelli AO, Wong W, Kim J, Chao S, Kurppa KJ, Yang X, Milenkowic K, Piccioni F, Root DE, Rücker FG, Flamand Y, Neuberg D, Lindsley RC, Jänne PA, Hahn WC, Jacks T, Döhner H, Armstrong SA, Ebert BL. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science. 2019 08 09; 365(6453):599-604. PMID: 31395785.
    Citations: 95     Fields:    Translation:HumansAnimalsCells
  20. Sperling AS, Burgess M, Keshishian H, Gasser JA, Bhatt S, Jan M, Slabicki M, Sellar RS, Fink EC, Miller PG, Liddicoat BJ, Sievers QL, Sharma R, Adams DN, Olesinski EA, Fulciniti M, Udeshi ND, Kuhn E, Letai A, Munshi NC, Carr SA, Ebert BL. Patterns of substrate affinity, competition, and degradation kinetics underlie biological activity of thalidomide analogs. Blood. 2019 07 11; 134(2):160-170. PMID: 31043423; PMCID: PMC6624968.
    Citations: 15     Fields:    Translation:HumansCells
  21. Singal G, Miller PG, Agarwala V, Li G, Kaushik G, Backenroth D, Gossai A, Frampton GM, Torres AZ, Lehnert EM, Bourque D, O'Connell C, Bowser B, Caron T, Baydur E, Seidl-Rathkopf K, Ivanov I, Alpha-Cobb G, Guria A, He J, Frank S, Nunnally AC, Bailey M, Jaskiw A, Feuchtbaum D, Nussbaum N, Abernethy AP, Miller VA. Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database. JAMA. 2019 04 09; 321(14):1391-1399. PMID: 30964529; PMCID: PMC6459115.
    Citations: 128     Fields:    Translation:Humans
  22. Kahn JD, Miller PG, Silver AJ, Sellar RS, Bhatt S, Gibson C, McConkey M, Adams D, Mar B, Mertins P, Fereshetian S, Krug K, Zhu H, Letai A, Carr SA, Doench J, Jaiswal S, Ebert BL. PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. 2018 09 13; 132(11):1095-1105. PMID: 29954749; PMCID: PMC6137556.
    Citations: 65     Fields:    Translation:HumansCells
  23. Miller PG, Ebert BL. Leukaemia: Vitamin C regulates stem cells and cancer. Nature. 2017 09 28; 549(7673):462-464. PMID: 28869971.
    Citations: 4     Fields:    Translation:HumansCells
  24. Coomber K, Mayshak R, Hyder S, Droste N, Curtis A, Pennay A, Gilmore W, Lam T, Chikritzhs T, Miller PG. Demographic and Substance Use Factors Associated with Non-Violent Alcohol-Related Injuries among Patrons of Australian Night-Time Entertainment Districts. Int J Environ Res Public Health. 2017 01 12; 14(1). PMID: 28085105.
    Citations: 1     Fields:    Translation:Humans
  25. Curtis A, Coomber K, Hyder S, Droste N, Pennay A, Jenkinson R, Mayshak R, Miller PG. Prevalence and correlates of drink driving within patrons of Australian night-time entertainment precincts. Accid Anal Prev. 2016 Oct; 95(Pt A):187-91. PMID: 27450790.
    Citations: 3     Fields:    Translation:Humans
  26. Coomber K, Pennay A, Droste N, Mayshak R, Martino F, Bowe SJ, Miller PG. Observable characteristics associated with alcohol intoxication within licensed entertainment venues in Australia. Int J Drug Policy. 2016 10; 36:8-14. PMID: 27450549.
    Citations: 3     Fields:    Translation:Humans
  27. Puram RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG, McConkey M, Tothova Z, Tejero H, Heckl D, Järås M, Chen MC, Li H, Tamayo A, Cowley GS, Rozenblatt-Rosen O, Al-Shahrour F, Regev A, Ebert BL. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell. 2016 Apr 07; 165(2):303-16. PMID: 27058663.
    Citations: 81     Fields:    Translation:HumansAnimalsCells
  28. Miller PG, Droste N, Curtis AJ, Pennay A, Jenkinson R. Drug testing, accuracy and harm reduction: a response to Barratt & Ezard. Addiction. 2016 Mar; 111(3):559-60. PMID: 26860250.
    Citations:    Fields:    Translation:HumansPHPublic Health
  29. Miller PG, Butler E, Richardson B, Staiger PK, Youssef GJ, Macdonald JA, Sanson A, Edwards B, Olsson CA. Relationships between problematic alcohol consumption and delinquent behaviour from adolescence to young adulthood. Drug Alcohol Rev. 2016 05; 35(3):317-25. PMID: 26494311.
    Citations: 6     Fields:    Translation:Humans
  30. Coomber K, Martino F, Barbour IR, Mayshak R, Miller PG. Do consumers 'Get the facts'? A survey of alcohol warning label recognition in Australia. BMC Public Health. 2015 Aug 22; 15:816. PMID: 26297551.
    Citations: 10     Fields:    Translation:Humans
  31. Chattopadhyay S, Stewart AL, Mukherjee S, Huang C, Hartwell KA, Miller PG, Subramanian R, Carmody LC, Yusuf RZ, Sykes DB, Paulk J, Vetere A, Vallet S, Santo L, Cirstea DD, Hideshima T, Dancík V, Majireck MM, Hussain MM, Singh S, Quiroz R, Iaconelli J, Karmacharya R, Tolliday NJ, Clemons PA, Moore MAS, Stern AM, Shamji AF, Ebert BL, Golub TR, Raje NS, Scadden DT, Schreiber SL. Niche-Based Screening in Multiple Myeloma Identifies a Kinesin-5 Inhibitor with Improved Selectivity over Hematopoietic Progenitors. Cell Rep. 2015 Feb 10; 10(5):755-770. PMID: 25660025.
    Citations: 13     Fields:    
  32. Miller PG, Curtis A, Sønderlund A, Day A, Droste N. Effectiveness of interventions for convicted DUI offenders in reducing recidivism: a systematic review of the peer-reviewed scientific literature. Am J Drug Alcohol Abuse. 2015 Jan; 41(1):16-29. PMID: 25321949.
    Citations: 13     Fields:    Translation:Humans
  33. Babor TF, Miller PG. Reply to Conibear (2014). Addiction. 2014 Aug; 109(8):1383-4. PMID: 25041208.
    Citations:    Fields:    Translation:Humans
  34. Graham K, Bernards S, Clapp JD, Dumas TM, Kelley-Baker T, Miller PG, Wells S. Street intercept method: an innovative approach to recruiting young adult high-risk drinkers. Drug Alcohol Rev. 2014 Jul; 33(4):449-55. PMID: 24890452.
    Citations: 4     Fields:    Translation:Humans
  35. Järås M, Miller PG, Chu LP, Puram RV, Fink EC, Schneider RK, Al-Shahrour F, Peña P, Breyfogle LJ, Hartwell KA, McConkey ME, Cowley GS, Root DE, Kharas MG, Mullally A, Ebert BL. Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia. J Exp Med. 2014 Apr 07; 211(4):605-12. PMID: 24616378.
    Citations: 47     Fields:    Translation:HumansAnimalsCells
  36. Miller PG, Hyder S, Zinkiewicz L, Droste N, Harris JB. Comparing subjective well-being and health-related quality of life of Australian drug users in treatment in regional and rural Victoria. Drug Alcohol Rev. 2014 Nov; 33(6):651-7. PMID: 24602061.
    Citations: 1     Fields:    Translation:Humans
  37. Babor TF, Miller PG. McCarthyism, conflict of interest and addiction's new transparency declaration procedures. Addiction. 2014 Mar; 109(3):341-4. PMID: 24524311.
    Citations: 7     Fields:    Translation:Humans
  38. Hartwell KA, Miller PG, Mukherjee S, Kahn AR, Stewart AL, Logan DJ, Negri JM, Duvet M, Järås M, Puram R, Dancik V, Al-Shahrour F, Kindler T, Tothova Z, Chattopadhyay S, Hasaka T, Narayan R, Dai M, Huang C, Shterental S, Chu LP, Haydu JE, Shieh JH, Steensma DP, Munoz B, Bittker JA, Shamji AF, Clemons PA, Tolliday NJ, Carpenter AE, Gilliland DG, Stern AM, Moore MAS, Scadden DT, Schreiber SL, Ebert BL, Golub TR. Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. Nat Chem Biol. 2013 Dec; 9(12):840-848. PMID: 24161946.
    Citations: 61     Fields:    Translation:HumansCells
  39. Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Järås M, Puram RV, Puissant A, Callahan KP, Ashton J, McConkey ME, Poveromo LP, Cowley GS, Kharas MG, Labelle M, Shterental S, Fujisaki J, Silberstein L, Alexe G, Al-Hajj MA, Shelton CA, Armstrong SA, Root DE, Scadden DT, Hynes RO, Mukherjee S, Stegmaier K, Jordan CT, Ebert BL. In Vivo RNAi screening identifies a leukemia-specific dependence on integrin beta 3 signaling. Cancer Cell. 2013 Jul 08; 24(1):45-58. PMID: 23770013.
    Citations: 86     Fields:    Translation:HumansAnimalsCells
  40. Sønderlund AL, O'Brien K, Kremer P, Rowland B, De Groot F, Staiger P, Zinkiewicz L, Miller PG. The association between sports participation, alcohol use and aggression and violence: a systematic review. J Sci Med Sport. 2014 Jan; 17(1):2-7. PMID: 23602563.
    Citations: 24     Fields:    Translation:Humans
  41. Coomber K, Miller PG, Livingston M, Xantidis L. Larger regional and rural areas in Victoria, Australia, experience more alcohol-related injury presentations at emergency departments. J Rural Health. 2013 Jun; 29(3):320-6. PMID: 23802934.
    Citations: 3     Fields:    Translation:Humans
  42. O'Brien KS, Lynott D, Miller PG. Alcohol industry sponsorship and alcohol-related harms in Australian university sportspeople/athletes. Drug Alcohol Rev. 2013 May; 32(3):241-7. PMID: 23121072.
    Citations: 2     Fields:    Translation:Humans
  43. Ashton JM, Balys M, Neering SJ, Hassane DC, Cowley G, Root DE, Miller PG, Ebert BL, McMurray HR, Land H, Jordan CT. Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. Cell Stem Cell. 2012 Sep 07; 11(3):359-72. PMID: 22863534.
    Citations: 35     Fields:    Translation:HumansAnimalsCells
  44. O'Brien KS, Kolt GS, Martens MP, Ruffman T, Miller PG, Lynott D. Alcohol-related aggression and antisocial behaviour in sportspeople/athletes. J Sci Med Sport. 2012 Jul; 15(4):292-7. PMID: 22178077.
    Citations: 5     Fields:    Translation:Humans
  45. Miller PG, de Groot F, McKenzie S, Droste N. Vested interests in addiction research and policy. Alcohol industry use of social aspect public relations organizations against preventative health measures. Addiction. 2011 Sep; 106(9):1560-7. PMID: 21781203.
    Citations: 22     Fields:    Translation:HumansPHPublic Health
  46. Skov SJ, Chikritzhs TN, Kypri K, Miller PG, Hall WD, Daube MM, Moodie AR. Is the "alcopops" tax working? Probably yes but there is a bigger picture. Med J Aust. 2011 Jul 18; 195(2):84-6. PMID: 21770879.
    Citations: 7     Fields:    Translation:Humans
  47. McKenzie SP, Leslie ER, Miller PG. Lower-alcohol, lower-calorie wines: harm reduction or harm production? Med J Aust. 2011 Jun 06; 194(11):614-5. PMID: 21644883.
    Citations:    Fields:    Translation:Humans
  48. O'Brien KS, Miller PG, Kolt GS, Martens MP, Webber A. Alcohol industry and non-alcohol industry sponsorship of sportspeople and drinking. Alcohol Alcohol. 2011 Mar-Apr; 46(2):210-3. PMID: 21278455.
    Citations: 8     Fields:    Translation:Humans
  49. Miller PG, Sønderlund AL. Using the internet to research hidden populations of illicit drug users: a review. Addiction. 2010 Sep; 105(9):1557-67. PMID: 20626378.
    Citations: 42     Fields:    Translation:Humans
  50. Miller PG, Coomber K, Staiger P, Zinkiewicz L, Toumbourou JW. Review of rural and regional alcohol research in Australia. Aust J Rural Health. 2010 Jun; 18(3):110-7. PMID: 20579021.
    Citations: 8     Fields:    Translation:Humans
  51. Miller PG, Hall W, West R, Marsden J, Darke S. A renewed call for action on alcohol policy. Addiction. 2010 May; 105(5):767-8. PMID: 20331570.
    Citations:    Fields:    Translation:Humans
  52. Miller PG, McKenzie SP, de Groot FP, Davoren SL, Leslie ER. The growing popularity of "low-carb" beers: good marketing or community health risk? Med J Aust. 2010 Feb 15; 192(4):235. PMID: 20170466.
    Citations:    Fields:    Translation:Humans
  53. Miller PG, Johnston J, Dunn M, Fry CL, Degenhardt L. Comparing probability and non-probability sampling methods in Ecstasy research: implications for the internet as a research tool. Subst Use Misuse. 2010 Feb; 45(3):437-50. PMID: 20141457.
    Citations: 6     Fields:    Translation:Humans
  54. Miller PG. Safe using messages may not be enough to promote behaviour change amongst injecting drug users who are ambivalent or indifferent towards death. Harm Reduct J. 2009 Jul 25; 6:18. PMID: 19630988.
    Citations: 3     Fields:    
  55. Miller PG, Kypri K, Chikritzhs TN, Skov SJ, Rubin G. Health experts reject industry-backed funding for alcohol research. Med J Aust. 2009 Jun 15; 190(12):713; discussion 714. PMID: 19527212.
    Citations: 3     Fields:    Translation:Humans
  56. Hofmann I, Stover EH, Cullen DE, Mao J, Morgan KJ, Lee BH, Kharas MG, Miller PG, Cornejo MG, Okabe R, Armstrong SA, Ghilardi N, Gould S, de Sauvage FJ, McMahon AP, Gilliland DG. Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis. Cell Stem Cell. 2009 Jun 05; 4(6):559-67. PMID: 19497284.
    Citations: 82     Fields:    Translation:AnimalsCells
  57. Miller PG, Miller WR. What should we be aiming for in the treatment of addiction? Addiction. 2009 May; 104(5):685-6. PMID: 19413777.
    Citations: 15     Fields:    Translation:Humans
  58. Miller PG, Lintzeris N, Forzisi L. Is groin injecting an ethical boundary for harm reduction? Int J Drug Policy. 2008 Dec; 19(6):486-91. PMID: 18024001.
    Citations: 2     Fields:    Translation:Humans
  59. Miller PG, Johnston J, McElwee PR, Noble R. A pilot study using the internet to study patterns of party drug use: processes, findings and limitations. Drug Alcohol Rev. 2007 Mar; 26(2):169-74. PMID: 17364852.
    Citations: 2     Fields:    Translation:Humans
  60. Ngantung FA, Miller PG, Brushett FR, Tang GL, Wang DI. RNA interference of sialidase improves glycoprotein sialic acid content consistency. Biotechnol Bioeng. 2006 Sep 05; 95(1):106-19. PMID: 16673415.
    Citations: 15     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Miller's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (274)
Explore
_
Co-Authors (105)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.